First H7N9 Avian Flu Vaccines Shown Effective in Trials
HONG KONG – Two new candidate vaccines against the virulent A(H7N9) avian influenza virus currently circulating in eastern China have been shown capable of inducing immunity in 80 percent to 85 percent of recipients, data from the first two Phase I trials suggest.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST